cholecystectomy. Retained cholelithiasis following cholecystectomy
Conditions
Interventions
Intervention 1: Intervention group 1: 0.5 mg / kg ephedrine will be prescribed. (Made by Biotica Pharmaceutical Company). Intervention 2: Intervention group 2: 0.05 mg / kg dexamethasone will be presc
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Candidate patients for laparoscopic cholecystectomy ASA class 1 and 2 No history of mental illness and psychosis No Parkinson's disease, motion sickness or history of chemotherapy Patients under general anesthesia Duration of surgery 60 to 150 minutes Lack of sensitivity to the drugs used No hypertension and no vascular problems
Exclusion criteria
Exclusion criteria: Patients without conscious consent Death of the patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of nausea. Timepoint: Recovery and 2, 4, 6, 12 and 24 hours after surgery. Method of measurement: Observation.;Vomiting. Timepoint: Up to 24 hours after surgery. Method of measurement: Score 0 to 4.;Severe nausea. Timepoint: Up to 24 hours after surgery. Method of measurement: Visual analog scale.;Sedation. Timepoint: In recovery and 1, 2 and 4 hours after surgery. Method of measurement: Ramsay score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Hesamedin Modir
Arak University of Medical Sciences
Outcome results
None listed